New Associated Pharma And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 4.75 M
as on 01-11-2024
- Paid Up Capital ₹ 4.65 M
as on 01-11-2024
- Company Age 4 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.00 Cr
as on 01-11-2024
- Revenue 87.78%
(FY 2023)
- Profit -1348.52%
(FY 2023)
- Ebitda 868.37%
(FY 2023)
- Net Worth -14824.30%
(FY 2023)
- Total Assets 92.06%
(FY 2023)
About New Associated Pharma And Research Centre
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.75 M and a paid-up capital of Rs 4.65 M.
The company currently has active open charges totaling ₹2.00 Cr.
Muraleedharan Nair, Ramadevi Balannair, Anisha, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24297KL2020PTC065686
- Company No.
065686
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kozhikode, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at New Associated Pharma And Research Centre?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Muraly Krishnan  | Managing Director | 11-Nov-2020 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Muraleedharan Nair | Director | 11-Nov-2020 | Current |
| Ramadevi Balannair | Director | 11-Nov-2020 | Current |
| Anisha | Director | 11-Nov-2020 | Current |
| Binisha | Director | 11-Nov-2020 | Current |
| Arunraj Rajendran | Director | 19-Dec-2020 | Current |
Financial Performance of New Associated Pharma And Research Centre.
New Associated Pharma And Research Centre Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 87.78% increase. The company also saw a substantial fall in profitability, with a 1348.52% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14824.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of New Associated Pharma And Research Centre?
Unlock access to New Associated Pharma And Research Centre's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Associated Clinical Aids Private LimitedActive 29 years 8 monthsMuraleedharan Nair, Ramadevi Balannair and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Apr 2023 | ₹2.00 Cr | Open |
How Many Employees Work at New Associated Pharma And Research Centre?
New Associated Pharma And Research Centre has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New Associated Pharma And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Associated Pharma And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
